Orange Book product · Generic (ANDA)
NABUMETONE
NABUMETONE
At a glance
Jun 13, 2011
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 13, 2011
15 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
NABUMETONE
Strength
500MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 091083
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NABUMETONE
- 1991RELAFENBrand (NDA)
NDA 019583 · SMITHKLINE BEECHAM
- 2025NABUMETONEGeneric (ANDA)
ANDA 219118 · NOVITIUM PHARMA
- 2019NABUMETONEGeneric (ANDA)
ANDA 203166 · LGM PHARMA
- 2011NABUMETONEGeneric (ANDA)
ANDA 090427 · MPP PHARMA
- 2011NABUMETONEGeneric (ANDA)
ANDA 090445 · ANNORA PHARMA
- 2010NABUMETONEGeneric (ANDA)
ANDA 090516 · AUROBINDO PHARMA USA
- 2009NABUMETONEGeneric (ANDA)
ANDA 079093 · OXFORD PHARMS
- 2008NABUMETONEGeneric (ANDA)
ANDA 078420 · SCIEGEN PHARMS
- 2008NABUMETONEGeneric (ANDA)
ANDA 078671 · INVAGEN PHARMS
- 2003NABUMETONEGeneric (ANDA)
ANDA 076009 · CHARTWELL MOLECULES
- 2002NABUMETONEGeneric (ANDA)
ANDA 075280 · CHARTWELL RX
- 2002NABUMETONEGeneric (ANDA)
ANDA 075590 · EPIC PHARMA LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
